Naisi Huang

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0001-7623-5744

发表论文 59 篇 · 总被引 901 次 · h-index 18

代表论文

• Integrated proteogenomic characterization of medullary thyroid carcinoma (2022 · Cell Discovery · 被引 66)
• New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research (2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 41)
• The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study (2023 · Annals of Surgical Oncology · 被引 25)
• Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study (2025 · Journal of the National Comprehensive Cancer Network · 被引 17)
• BRAF V600E /p-ERK/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer (2024 · Thyroid · 被引 16)
• Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System (2023 · Clinical Cancer Research · 被引 11)